Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Vabysmo 6mg Injection
Manufacturer/Marketed By : ROCHE PRODUCTS INDIA PVT LTD
$732.70 $619.85
Vabysmo 6mg Injection contains the active ingredient Faricimab, a humanised bispecific antibody. It targets and inhibits two pathways: VEGF-A and Ang-2. This reduces fluid buildup, controls abnormal blood vessel growth,...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
FARICIMAB
Active Pharmaceutical Ingredient
Vabysmo 6mg Injection
$732.70
$619.85
Vabysmo 6mg Injection contains the active ingredient Faricimab, a humanised bispecific antibody. It targets and inhibits two pathways: VEGF-A and Ang-2. This reduces fluid buildup, controls abnormal blood vessel growth, and stabilises retinal health. Vabysmo 6mg Injection is used to treat conditions such as Diabetic Macular Edema (DME), Wet Age-Related Macular Degeneration (AMD), Retinal Vein Occlusion (RVO), and Myopic Choroidal Neovascularization (mCNV), which cause significant vision problems. Vabysmo 6mg Injection improves vision by addressing these underlying issues and promoting retinal stability. Vabysmo 6mg Injection must be administered by a healthcare professional in a controlled setting. It can cause serious risks such as eye infections, retinal detachment, increased intraocular pressure, and blood clots, potentially leading to strokes or heart attacks. Healthcare providers will determine the dosage and treatment schedule based on the patient’s condition. Regular monitoring and follow-up visits are essential for optimal results. Always consult your healthcare provider before starting Vabysmo 6mg Injection, especially if you are pregnant, breastfeeding, or planning pregnancy.
Active Pharmaceutical Ingredient
Uses
• Diabetic macular edema (DME)
• Wet age-related macular degeneration (AMD)
• Retinal vein occlusion (RVO)
• Myopic choroidal neovascularisation (mCNV)
Benefits
Vabysmo 6mg Injection is a humanised bispecific antibody that targets VEGF-A and Ang-2. It suppresses endothelial cell growth and vascular permeability by binding to VEGF-A while promoting vascular stability and reducing sensitivity to VEGF-A by targeting Ang-2. The role of Ang-2 inhibition in treating nAMD and DME is not yet fully understood.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Most Common Side Effects
• Corneal abrasion
• Eye pruritus & Increased lacrimation
• Ocular hyperemia
• Blurred vision & Eye irritation
• The sensation of a foreign body in the eye
• Endophthalmitis
• Retinal tear
• Rhegmatogenous retinal detachment
Common Side Effects
• Conjunctival hemorrhage
• Vitreous floaters
• Retinal pigment epithelial tear
• Increased intraocular pressure & inflammation
• Eye pain & Ocular discomfort
• Vitreous haemorrhage
How To Use
Vabysmo 6mg Injection should be administered in a healthcare setting, typically by an eye care specialist. The dose will be determined by the doctor based on the specific condition being treated. It is given through an intravitreal injection (injection into the eye), and the treatment schedule may vary depending on the patient's condition and response to therapy. Always follow the doctor's instructions for dosing and administration.
Safety Advice
• Breast Feeding: It is unknown if Vabysmo 6mg Injection is safe to use while breastfeeding. Please consult your healthcare provider before use if you are breastfeeding.
• Alcohol: It is unknown if Vabysmo 6mg Injection is safe to use while having alcohol. Please consult your healthcare provider before using Vabysmo 6mg Injection.
• Liver: You need to inform your doctor if you have any liver disorders before starting treatment with Vabysmo 6mg Injection.
• Lungs: Before starting treatment with Vabysmo 6mg Injection, talk to your doctor if you have any lung conditions.
• Driving: After your treatment with Vabysmo 6mg Injection, you may have temporary vision problems (for example, blurred vision). Do not drive or use machines as long as these last.
• Pregnancy: It is unknown whether it is safe to use Vabysmo 6mg Injection during pregnancy. Please consult your healthcare provider before starting treatment with Vabysmo 6mg Injection.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.